Ulcerative Colitis Clinical Trials in Philadelphia

Showing 601-620 of 731 trials

Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent: Extended Follow-up of the Premarket Cohort

NCT01836042

The purpose of this study is to assess the long-term safety of the Glaukos® iStent® Trabecular Micro-Bypass Stent Model GTS100R/L in subjects previously enrolled in Glaukos Study GC-003.

Primary Open Angle Glaucoma

Glaukos Corporation108 participantsStarted Jul 2013

Beverly Hills, California, United States • Petaluma, California, United States • Sacramento, California, United States +23 more locations

COMPLETEDPhase 2< 1 mile

A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis

NCT00323518

CG53135-05 (velafermin), a recombinant human fibroblast growth factor-20 (rhFGF-20) protein, is under investigation for the prevention of oral mucositis. Oral mucositis is a commonly occurring side effect of high-dose chemotherapy in patients undergoing autologous hematopoietic stem cell transplant. The objective of this Phase II trial is to confirm the safety and efficacy of CG53135-05 (velafermin) when administered as a single dose to patients at risk for developing oral mucositis.

Oral MucositisStomatitis

CuraGen Corporation390 participantsStarted May 2006

Little Rock, Arkansas, United States • Berkley, California, United States • La Jolla, California, United States +30 more locations

Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent: Extended Follow-up of the Premarket Cohort

A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis

Ulcerative Colitis Trials in Other Cities

Obstructive Sleep Apnea and Neurocognitive and Cardiovascular Function in Children With Down Syndrome

Childhood Adenotonsillectomy Study for Children With OSAS

The Efficacy of Early Amniotomy for Induction of Labor

Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)

Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy

Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Glycopyrrolate/Formoterol Fumarate MDI Compared With Spiriva® as An Active Control in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation.

Developing a COPD Case Finding Methodology for Primary Care

Cervical Preparation Before Dilation and Evacuation

AqueSys Microfistula Implant in Refractory Glaucoma

Safety and Exercise Study of Two Doses of BMN 110 for Morquio A Syndrome

Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2)

BYM338 in Chronic Obstructive Pulmonary Disease (COPD) Patients With Cachexia

Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients

Comparison of Long-term Safety of the Combination Product QVA149A Against Placebo and Standard of Care Treatment in Chronic Obstructive Pulmonary Disease Patients With Moderate to Severe Airflow Limitation

Other Conditions in Philadelphia